Both masses were confirmed as grade 2 invasive ductal carcinomas (IDCs) of no special type (NST), estrogen receptor (ER)-positive (8/8), progesterone receptor (PR)-positive (7/8), HER2-negative, and with Ki-67 of 10-15%. Here, ESR1 is linked to invasive ductal breast carcinoma.